Red-light therapy has become a wellness darling, with manufacturers claiming it treats acne, hair loss, depression, chronic pain, and dozens of other conditions. New Scientist reports that while many of these promises are exaggerated, legitimate scientific evidence does support some benefits, though often not the ones consumers expect.

The therapy uses wavelengths between 600 and 1000 nanometers to stimulate cells. Proponents argue it boosts mitochondrial function and increases ATP production, energizing cells to heal faster. Research published in peer-reviewed journals shows red-light therapy can accelerate wound healing and reduce inflammation in specific contexts.

The strongest evidence backs red-light therapy for wound healing and certain skin conditions. Studies demonstrate it promotes collagen production and increases blood flow to affected areas, speeding recovery from cuts and minor injuries. Some research supports its use for specific types of pain management, particularly musculoskeletal conditions.

However, evidence for treating depression, hair loss, and acne remains mixed or weak. While some studies show positive results, others fail to replicate these findings, and most suffer from small sample sizes or poor experimental design. The therapy's effects depend heavily on wavelength, intensity, duration, and individual factors that manufacturers often ignore in marketing.

The fundamental problem lies in the gap between marketing claims and rigorous science. Wellness companies tout red-light therapy as a cure-all, flooding social media with testimonials while glossing over limitations. Consumers purchase expensive devices based on these exaggerated promises, often seeing no results.

Researchers emphasize that red-light therapy works best when combined with conventional treatments rather than replacing them. A person treating a wound benefits from red-light therapy alongside proper medical care, not instead of it. The therapy shows promise for specific applications where controlled studies have validated efficacy, but broader claims require more rigorous investigation before acceptance.